Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
Conditions: Type2 Diabetes; Obesity Interventions: Drug: 0.9% Sodium-chloride; Drug: Exenatide (50ng/min for 30 minutes loading followed by 25ng/min maintenance) and glucagon 12.5ng/kg/min Sponsors: Cambridge University Hospitals NHS Foundation Trust; Antaros Medical AB Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Byetta | Cambridge University | Chloride | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Foundation Trusts | Hospitals | Obesity | Research | Sodium | Sodium Chloride